Investigators from Great Ormond Street Hospital, and Institute of Child Health, London, UK, reviewed the case notes of all patients treated with methylphenidate (MPH) for ADHD at an epilepsy center between 1998 and 2005
Objective: To study the safety and efficacy of methylphenidate in children with the dual diagnosis o...
The acute effects of methylphenidate (MPH) in 3 dosages (0.3, 0.6, and 0.9 mg/kg) on the performance...
The safety and efficacy of methylphenidate (MPH), 0.3 and 0.6 mg/kg, in 11 preschool children (aged ...
Investigators from the Department of Functional Neurology, Epileptology and Epilepsy Institute (IDEE...
The safety and efficacy of methylphenidate (MPH) in the treatment of ADHD, group 1) with epilepsy an...
WOS: 000181922500005PubMed: 12693777Methylphenidate is commonly believed to lower seizure threshold....
The safety and efficacy of immediate-release methylphenidate (MPH-IR) for the treatment of attention...
The usage and usage trends for methylphenidate (MPH) treatment of ADHD from 1990 through 1995 were e...
Twenty-four participants with uncontrolled epilepsy and ADHD in this prospective study, conducted at...
The therapeutic effectiveness of methylphenidate (MPH) (0.3 mg/kg) in attention-deficit hyperactivit...
Abstract Attention deficit hyperactivity disorder (ADHD) is the most commonly diagnosed neurobehavio...
Methylphenidate (MPH) is the most common drug treatment of attention deficit / hyperactivity disorde...
Methylphenidate (MPH), the most common medication for children with Attention Deficit/Hyperactivity ...
Methylphenidate (MPH), the most common medication for children with Attention Deficit/Hyperactivity ...
The effects of methylphenidate (MPH) administered at 4 PM on behavior and sleep in 12 child psychiat...
Objective: To study the safety and efficacy of methylphenidate in children with the dual diagnosis o...
The acute effects of methylphenidate (MPH) in 3 dosages (0.3, 0.6, and 0.9 mg/kg) on the performance...
The safety and efficacy of methylphenidate (MPH), 0.3 and 0.6 mg/kg, in 11 preschool children (aged ...
Investigators from the Department of Functional Neurology, Epileptology and Epilepsy Institute (IDEE...
The safety and efficacy of methylphenidate (MPH) in the treatment of ADHD, group 1) with epilepsy an...
WOS: 000181922500005PubMed: 12693777Methylphenidate is commonly believed to lower seizure threshold....
The safety and efficacy of immediate-release methylphenidate (MPH-IR) for the treatment of attention...
The usage and usage trends for methylphenidate (MPH) treatment of ADHD from 1990 through 1995 were e...
Twenty-four participants with uncontrolled epilepsy and ADHD in this prospective study, conducted at...
The therapeutic effectiveness of methylphenidate (MPH) (0.3 mg/kg) in attention-deficit hyperactivit...
Abstract Attention deficit hyperactivity disorder (ADHD) is the most commonly diagnosed neurobehavio...
Methylphenidate (MPH) is the most common drug treatment of attention deficit / hyperactivity disorde...
Methylphenidate (MPH), the most common medication for children with Attention Deficit/Hyperactivity ...
Methylphenidate (MPH), the most common medication for children with Attention Deficit/Hyperactivity ...
The effects of methylphenidate (MPH) administered at 4 PM on behavior and sleep in 12 child psychiat...
Objective: To study the safety and efficacy of methylphenidate in children with the dual diagnosis o...
The acute effects of methylphenidate (MPH) in 3 dosages (0.3, 0.6, and 0.9 mg/kg) on the performance...
The safety and efficacy of methylphenidate (MPH), 0.3 and 0.6 mg/kg, in 11 preschool children (aged ...
DOI
Add to ORKG